Key statistics
On Monday, Veracyte Inc (12V:BER) closed at 30.00, -4.46% below its 52-week high of 31.40, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.00 |
---|---|
High | 30.00 |
Low | 30.00 |
Bid | 30.80 |
Offer | 31.00 |
Previous close | 29.80 |
Average volume | 43.50 |
---|---|
Shares outstanding | 76.81m |
Free float | 76.18m |
P/E (TTM) | -- |
Market cap | 2.52bn USD |
EPS (TTM) | -0.7444 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:01 BST.
More ▼
Press releases
- New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
- New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
- Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle
- Veracyte Announces Second Quarter 2024 Financial Results
- Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024
More ▼